A5070392949- Nanoparticle-Based Drug Delivery
- Nanoplatforms for cancer theranostics
- Electrospun Nanofibers in Biomedical Applications
- Cancer, Hypoxia, and Metabolism
- 3D Printing in Biomedical Research
- Cancer Cells and Metastasis
- Dendrimers and Hyperbranched Polymers
- MicroRNA in disease regulation
- Advanced Cellulose Research Studies
- Reproductive System and Pregnancy
- Advanced Nanomaterials in Catalysis
- biodegradable polymer synthesis and properties
- RNA Interference and Gene Delivery
- Tissue Engineering and Regenerative Medicine
- Extracellular vesicles in disease
- Garlic and Onion Studies
- Advanced biosensing and bioanalysis techniques
- Cancer, Stress, Anesthesia, and Immune Response
- ATP Synthase and ATPases Research
- Cholinesterase and Neurodegenerative Diseases
- Microfluidic and Bio-sensing Technologies
- Histone Deacetylase Inhibitors Research
- Biopolymer Synthesis and Applications
- Quantum Dots Synthesis And Properties
- Cancer-related Molecular Pathways
Tabriz University of Medical Sciences
2021-2024
Abstract Advanced forms of hydrogels have many inherently desirable properties and can be designed with different structures functions. In particular, bioresponsive multifunctional carry out sophisticated biological These include in situ single‐cell approaches, capturing, analysis, release living cells, biomimetics cell, tissue, tumor‐specific niches. They allow vivo cell manipulation act as novel drug delivery systems, allowing diagnostic, therapeutic, vaccination, immunotherapy methods....
In this research, an innovative protocol is introduced to address crucial deficiencies in the formulation of chitosan nanoparticles (Cs NPs). While NPs show potential drug delivery systems (DDSs), their application clinic hindered by various drawbacks, such as toxicity, high material costs, and time-consuming challenging preparation procedures. Within polymer-based NPs, Cs a plentiful natural substance derived from deacetylation chitin, which can be sourced shells shrimp or crab. formulated...
Purpose: We report on the design of hypoxia-induced dual-stage acting dendrimeric nanoparticles (NPs) for selective delivery two chemotherapeutic model drugs doxorubicin (DOX) and tirapazamin (TPZ) deepened drug into hypoxic tumors in vitro. Methods: PAMAM G5 dendrimers were crosslinked with a azo linker, attached to mPEG form detachable corona dendrimer surface (PAP NPs). NPs characterized by Zeta sizer, transmission electron microscope (TEM), Fourier transforms infrared (FTIR) release...